(Q22252312)

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Heterogeneous expression of Wnt/beta-catenin target genes within colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cancer incidence and risk factors after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Autophagy-A double-edged sword in oncology

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Angiogenic signalling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Thrombospondins in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Pericytes: gatekeepers in tumour cell metastasis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Sprouty proteins, masterminds of receptor tyrosine kinase signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

EMT, the cytoskeleton, and cancer cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Bone marrow-derived mesenchymal stem cells and the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cell signalling: growth factors and tyrosine kinase receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Short telomeres limit tumor progression in vivo by inducing senescence

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Tumor cell metabolism: cancer's Achilles' heel

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Life in the balance: how BH3-only proteins induce apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

ErbB receptors and signaling pathways in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Autophagy and metastasis: another double-edged sword

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Role of autophagy in suppression of inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The epigenomics of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Autophagy in the Pathogenesis of Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The epithelial-mesenchymal transition generates cells with properties of stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

1 reference

7 January 2021

Cancer cell metabolism: Warburg and beyond

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Necroptosis: a specialized pathway of programmed necrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Principles of cancer therapy: oncogene and non-oncogene addiction

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Epithelial-mesenchymal transitions in development and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Tumor self-seeding by circulating cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Immunity, Inflammation, and Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Lymphangiogenesis: Molecular mechanisms and future promise

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Macrophage diversity enhances tumor progression and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Matrix metalloproteinases: regulators of the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cell signaling by receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Natural immunity to cancer in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Pathways mediating VEGF-independent tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Tumors as organs: complex tissues that interface with the entire organism

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cancer dissemination--lessons from leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Aberrant epigenetic landscape in cancer: how cellular identity goes awry

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

DNA repair: From molecular mechanism to human disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Angiogenesis in pre-malignant conditions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Mechanisms of resistance to antiangiogenesis therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cellular abnormalities of blood vessels as targets in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Recent advances in cancer stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cellular senescence: hot or what?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

HIF-1: upstream and downstream of cancer metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Breast cancer genomes--form and function

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Endogenous inhibitors of angiogenesis: a historical review

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Lack of collagen XVIII accelerates cutaneous wound healing, while overexpression of its endostatin domain leads to delayed healing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The DNA damage response: ten years after

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The DNA Damage Response: Making It Safe to Play with Knives

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Involvement of endothelial progenitor cells in tumor vascularization

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Resident vascular progenitor cells: an emerging role for non-terminally differentiated vessel-resident cells in vascular biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The angiogenic switch in carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Co-evolution of tumor cells and their microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cysteine cathepsin proteases as pharmacological targets in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Hallmarks of cancer: interactions with the tumor stroma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Activation of fibroblasts in cancer stroma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Stem cells in tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

PI3K/PTEN signaling in angiogenesis and tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Regulatory T cells in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cellular senescence: mitotic clock or culture shock?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Transmission of donor melanoma by organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The RB and p53 pathways in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Hayflick, his limit, and cellular ageing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Stem cells, cancer, and cancer stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cancer-susceptibility genes. Gatekeepers and caretakers

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cancer without disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cancer: The nuances of therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cancer: Genomic evolution of metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Mice without telomerase: what can they teach us about human cancer?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Regulation of death receptor signaling by the ubiquitin system

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Actions of human telomerase beyond telomeres

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Stromal fibroblasts in cancer initiation and progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Intrinsic tumour suppression

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Efficient tumour formation by single human melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Genes that mediate breast cancer metastasis to the brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Telomerase modulates Wnt signalling by association with target gene chromatin

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The DNA-damage response in human biology and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Glioblastoma stem-like cells give rise to tumour endothelium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

In situ analyses of genome instability in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

A module of negative feedback regulators defines growth factor signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cancer stem cells: mirage or reality?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Tumorigenesis and the angiogenic switch

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cell adhesion and signalling by cadherins and Ig-CAMs in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Paradoxical roles of the immune system during cancer development

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cysteine cathepsins: multifunctional enzymes in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Making a tumour's bed: glioblastoma stem cells and the vascular niche.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Role of autophagy in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Models, mechanisms and clinical evidence for cancer dormancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cellular mechanisms of tumour suppression by the retinoblastoma gene.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Modes of resistance to anti-angiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The role of myeloid cells in the promotion of tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Derailed endocytosis: an emerging feature of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Microenvironmental regulation of metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Metastasis: from dissemination to organ-specific colonization

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Parallel progression of primary tumours and metastases

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

p53--a Jack of all trades but master of none

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Senescence in tumours: evidence from mice and humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Eph receptors and ephrins in cancer: bidirectional signalling and beyond

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

TGFbeta signalling: a complex web in cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Specialization of tumour vasculature

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Targeting microRNAs in cancer: rationale, strategies and challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Telomeres and human disease: ageing, cancer and beyond

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cancer epigenomics: DNA methylomes and histone-modification maps

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Complex networks orchestrate epithelial-mesenchymal transitions

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cancer as an overhealing wound: an old hypothesis revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Genomic instability--an evolving hallmark of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Antiangiogenic therapies for high-grade glioma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Imaging angiogenesis of genitourinary tumors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

PI3K pathway alterations in cancer: variations on a theme

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

LKB1; linking cell structure and tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Immune infiltration in human tumors: a prognostic factor that should not be ignored

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The autophagy effector Beclin 1: a novel BH3-only protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Analysis of the genome to personalize therapy for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cancer-associated IDH mutations: biomarker and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Mouse models in tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The retinoblastoma gene family in differentiation and development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Disparate effects of telomere attrition on gene expression during replicative senescence of human mammary epithelial cells cultured under different conditions

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cyclins and cdks in development and cancer: a perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The Bcl-2 apoptotic switch in cancer development and therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Heterogeneity of the tumor vasculature

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Oncogene-induced cell senescence--halting on the road to cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The telomerase reverse transcriptase regulates chromatin state and DNA damage responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Prospective identification of tumorigenic breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Transdifferentiation of glioblastoma cells into vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Systems biology of vascular endothelial growth factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Contact-dependent inhibition of EGFR signaling by Nf2/Merlin

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Plasticity of cell migration: a multiscale tuning model

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Targeting of drugs and nanoparticles to tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The effects of surgery on tumor growth: a century of investigations

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Telomeres and telomerase in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

DNA damage in telomeres and mitochondria during cellular senescence: is there a connection?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Corrupt policemen: inflammatory cells promote tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Involvement of members of the cadherin superfamily in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Necrotic death as a cell fate

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Autophagy: process and function

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Tumor suppressors and cell metabolism: a recipe for cancer growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Identifying site-specific metastasis genes and functions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Cancer immunoediting from immune surveillance to immune escape

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Tumor-vascular interactions and tumor dormancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Polarized immune responses differentially regulate cancer development

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The impact of T-cell immunity on ovarian cancer outcomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Understanding the Warburg effect: the metabolic requirements of cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

On the Origin of Cancer Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

A matter of life and cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Tumor suppression by LKB1: SIK-ness prevents metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The biology of cancer stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Repair and genetic consequences of endogenous DNA base damage in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

1 reference

7 January 2021

Mutational heterogeneity in human cancers: origin and consequences.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Roles for growth factors in cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Endogenous inhibitors of angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Tube travel: the role of proteases in individual and collective cancer cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

AACR centennial series: the biology of cancer metastasis: historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The roles of therapy-induced autophagy and necrosis in cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The double-edged sword of autophagy modulation in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

VEGF as a key mediator of angiogenesis in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Unraveling the obesity and breast cancer links: a role for cancer-associated adipocytes?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Endothelial-mural cell signaling in vascular development and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The bone marrow constitutes a reservoir of pericyte progenitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Immune-mediated dormancy: an equilibrium with cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Dual roles for immunity in gastrointestinal cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Angiogenesis in endocrine tumors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The role of pericytes in blood-vessel formation and maintenance

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

The Snail genes as inducers of cell movement and survival: implications in development and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Telomere length and telomerase expression in atypical adenomatous hyperplasia and small bronchioloalveolar carcinoma of the lung.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Generation of breast cancer stem cells through epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Ectopic expression of the catalytic subunit of telomerase protects against brain injury resulting from ischemia and NMDA-induced neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Novel imaging provides new insights into mechanisms of oxygen transport in tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Molecular Pathways Linking Inflammation and Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Chemokine networks and breast cancer metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Myeloid-derived suppressor cells: linking inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

Dormancy of solitary metastatic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021

3D view to tumor suppression: Lkb1, polarity and the arrest of oncogenic c-Myc

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.013

7 January 2021